Beyond Air to Implement 1-for-20 Reverse Stock Split Effective July 14
Beyond Air announces a 1-for-20 reverse stock split effective July 14 to enhance stock liquidity and meet listing requirements. #BeyondAir #ReverseStockSplit
Executive Summary
Beyond Air, Inc. (Beyond Air), a clinical-stage medical technology company focused on developing inhaled nitric oxide therapies, has announced a 1-for-20 reverse stock split effective July 14, 2025. This strategic move aims to increase the per-share price of its common stock, improve marketability, and maintain compliance with stock exchange listing standards.
Company Overview
Founded in 2006 and headquartered in New York, Beyond Air develops innovative inhaled nitric oxide (NO) therapies for respiratory diseases, including COVID-19 and pulmonary infections. The company’s flagship product, LungFit®, is designed to deliver therapeutic doses of NO via a portable device.
Details of the Reverse Stock Split
The reverse stock split will consolidate every 20 shares of common stock into one share, reducing the total number of outstanding shares proportionally. Shareholders will receive one new share for every 20 shares held prior to the split. The company expects the reverse split to increase the stock price, potentially attracting institutional investors and improving liquidity.
Recent Financial Performance (2021-2024)
| Fiscal Year | Revenue (USD Millions) | Net Loss (USD Millions) | Cash & Equivalents (USD Millions) |
|---|---|---|---|
| 2021 | 0.5 | (15.0) | 10.0 |
| 2022 | 0.8 | (18.5) | 8.0 |
| 2023 | 1.2 | (20.0) | 6.5 |
| 2024 (Projected) | 2.0 | (15.0) | 7.0 |
Strategic Implications
The reverse stock split is intended to enhance Beyond Air’s stock price stability and meet the minimum bid price requirements of major stock exchanges. This action may also improve investor perception and facilitate future capital raising efforts.
Risks and Considerations
- Potential short-term volatility following the reverse split.
- Risk of shareholder dilution if additional shares are issued.
- Market reaction to reverse splits can be mixed, requiring clear communication.
Conclusion
Beyond Air’s 1-for-20 reverse stock split effective July 14, 2025, is a strategic step to strengthen its market position and support ongoing development of its inhaled nitric oxide therapies. Investors should monitor trading activity and company updates closely.